Philippe Calais

Insider Reports History

Entity
Individual
Location
C/O Marina Biotech, Inc., 17870 Castleton Street, Suite 250, City Of Industry, CA
Signature
/s/ Thomas A. Fitzgerald, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Philippe Calais:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Transcode Therapeutics, Inc. Director Stock Option (right to buy) 70K Jun 14, 2024 Direct

Insider Reports Filed by Philippe Calais

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RNAZ Transcode Therapeutics, Inc. Jun 14, 2024 1 $0 4 Jun 18, 2024 Director
RNAZ Transcode Therapeutics, Inc. May 19, 2023 1 $0 4 May 19, 2023 Director
RNAZ Transcode Therapeutics, Inc. May 10, 2023 1 $0 4 May 10, 2023 Director
RNAZ Transcode Therapeutics, Inc. Jun 22, 2022 1 $0 4 Jun 22, 2022 Director
RNAZ Transcode Therapeutics, Inc. Jul 8, 2021 0 $0 3 Jul 8, 2021 Director